1- Research Center for Social Determinants of Health, Jahrom University of Medical Sciences, Jahrom, Iran. & Iranian Research Network for Social Determinants of Health (IRNSDH), Tehran, Iran., Research Center for Social Determinants of Health, Jahrom University of Medical Sciences, Jahrom, Iran. , yasersarikhani@yahoo.com 2- Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran., Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran.
Abstract: (13 Views)
Abstract Background: Tuberculosis (TB) remains one of the most significant public health challenges, and monitoring its long-term trends is essential for evaluating the effectiveness of disease control programs. This study aimed to assess the 30-year trend of TB prevalence and disease burden in Iran from 1994 to 2023. Methods: This ecological descriptive study was conducted using data from the Global Burden of Disease study. Indicators of TB prevalence and disability-adjusted life years (DALYs) in Iran, the Eastern Mediterranean Region, and globally were extracted and analyzed as age-standardized rates per 100,000 population. Temporal trends were assessed using the Joinpoint regression model and the average annual percent change (AAPC), with a significance level set at 0.05. Results: The findings indicated a decreasing trend in both DALYs and TB prevalence, with AAPCs of −4.50 and −0.39, respectively (P < 0.001). In subgroups, both DALYs and prevalence of drug-susceptible TB showed declining trends, whereas multidrug-resistant TB and extensively drug-resistant TB demonstrated increasing trends (P < 0.001). Conclusion: Although the overall burden of TB in Iran has declined over the past three decades, the rising trend of drug-resistant forms highlights the continued need for strengthened early detection, surveillance of drug resistance, and targeted treatment strategies.
Type of Study: Original |
Subject: General Received: 2026/05/19 | Accepted: 2026/07/6
Send email to the article author
Add your comments about this article
Research code: 403000154
Ethics code: IR.JUMS.REC.1403.109
Clinical trials code: NA
Open Access Statement: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium or format, provided that the original work is properly cited.